Castle biosciences’s stock is considered to be oversold (<=20). (nasdaq:cstl) was the target of a significant decrease in short interest in october.
Now trade stocks online commission free with charles schwab, a.
Castle biosciences stock news. Derek maetzold, insider at castle biosciences (nasdaq:cstl), made a large buy and sell of company shares on. Positive dynamics for castle biosciences shares will prevail with possible volatility of 2.365%. Castle biosciences will release figures for the most recent quarter on november 9.
This compares to loss of $0.23 per share a. Get the latest castle biosciences stock price and detailed information including cstl news, historical charts and realtime prices. On average, they anticipate castle biosciences' stock price to reach $78.83 in the next twelve months.
As of october 15th, there was short interest totalling 992,900 shares, a decrease of 16.6% from the september 30th total of 1,190,000 shares. At castle biosciences, we promise to treat your data with respect and will not share your information with any third party. Castle biosciences’s stock yearly top and bottom value.
Cstl) is a leading diagnostics company that provides personalized, clinically actionable information to clinicians and patients to inform treatment decisions and improve health outcomes. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. ( cstl) has agreed to snap up an illumina ventures company, cernostics, inc., in a.
Stock news nasdaq:cstl svb leerink cuts castle biosciences (nasdaq:cstl) price target to $75.00 08:14am, thursday, 11'th nov 2021 transcript daily Their forecasts range from $52.00 to $94.00. The company is focused on transforming the disease management paradigm in skin cancer and other diseases with high clinical need by.
If you experience any issues with. Real time castle biosciences inc (cstl) stock price quote, stock graph, news & analysis. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Castle biosciences shares are trading down 0.33% at $52.23 at the time of this writing on thursday morning. Cstl | complete castle biosciences inc. Approximately 5.6% of the company's stock are short sold.
Castle biosciences inc (cstl) shares closed today at 0.8% above its 52 week low of $42.78, giving the company a market cap of $1b. (cstl) stock price quote with breaking news, financials, statistics, charts and more. Analysts are expecting losses per share of $0.405.
(cstl) came out with a quarterly loss of $0.47 per share versus the zacks consensus estimate of a loss of $0.35. Notable castle biosciences insider trades $960k in company stock.
